loading page

Comment on: Safety and feasibility of hemodynamic pulmonary artery pressure monitoring using the CardioMEMS device in LVAD management
  • J Breda
J Breda
Miami Transplant Institute
Author Profile


The called burden of cardiac heart failure (CHF) on healthcare systems and economies remains large and a major factor contributing to this burden is the high hospital admission rate for acute decompensated heart failure. These repeated heart failure hospitalizations (HFH) not only exert a high burden on healthcare systems, but also impact patient quality of life and have been associated with impaired prognosis and reduced life expectancy. The need for remote monitoring has become extremely important, mainly based on devices capable of measuring intracardiac filling pressures. If we assume that hemodynamic congestion precedes clinical congestion, the hemodynamic monitoring could be able to detect early signs of congestion and enables clinicians to intervene in a pre-symptomatic phase avoiding hospital admission. Dr. Veenis JF and colleagues present the results of implanting the CardioMEMS device in 10 patients who underwent heartmate 3 implantation. The authors describe the study design based on an earlier publication by the same author. The authors argue that the use of this device will allow the monitoring of patients pre, during hospitalization and after implantation, with a possible reduction in the number of readmissions for allowing the diagnosis and treatment of complications related to ventricular failure and volume overload.

Peer review status:IN REVISION

07 May 2021Submitted to Journal of Cardiac Surgery
18 May 2021Submission Checks Completed
18 May 2021Assigned to Editor
18 May 2021Editorial Decision: Revise Minor
24 May 20211st Revision Received
12 Jun 2021Submission Checks Completed
12 Jun 2021Assigned to Editor
12 Jun 2021Review(s) Completed, Editorial Evaluation Pending
12 Jun 2021Editorial Decision: Revise Minor